Note: This article is the first in a series. January 8, 2015—A little over nine years ago, Congress wanted to know why health care providers had no way to tell whether they were being overcharged for 340B discounted drugs. … [Read more...]
HRSA Clarifies 340B Duplicate Discount Policy
Says exclusion file does not pertain to Medicaid managed careDecember 16, 2014—The database that the Health Resources and Services Administration maintains to protect drugmakers from paying both 340B discounts and Medicaid rebates on the same drugs applies only to Medicaid fee-for-service and not to Medicaid managed care claims, HRSA clarified yesterday in an updated 340B policy release. … [Read more...]
The Top Ten 340B Stories of 2014
Regulations were our readers' leading preoccupationDecember 16, 2014—For the 340B community, 2014 will go down as the year that a federal court invalidated the 340B orphan drug exclusion regulation, derailing the long-awaited 340B "mega-reg" plus other program regulations in the works. … [Read more...]
Spending Bill’s Report Contains 340B Directives
Appropriators address ceiling price availability, patients' access to savingsDecember 10, 2014—House and Senate appropriators agreed yesterday on a $1.1 trillion fiscal 2015 federal spending bill with report language about the 340B program. Congress has yet to vote on the measure. … [Read more...]
340B Addressed During House Hearing on Health Spending
Health panel's chair asks if it's time to re-evaluate programDecember 10, 2014—The chairman of the House Energy & Commerce Health Subcommittee asked during a hearing yesterday whether the 340B program should be re-evaluated. … [Read more...]
340B Proposed Regulations Penciled in for April and September
The first is on pricing and manufacturer sanctions, second is on dispute resolutionDecember 3, 2014—The Health Resources and Services Administration plans to publish two 340B program regulations next year, one in April and the other in September, according to the federal government's latest agenda of upcoming regulatory actions. … [Read more...]
Bill Would Extend Medicaid Drug Rebate Inflation Penalty to Generics
Measure doesn't mention 340B, but it also might affect drug discountsDecember 2, 2014—Two members of Congress who have been investigating rising generic drug prices have introduced legislation that would require generic drugmakers to provide larger Medicaid drug rebates whenever their products' prices rise faster than the rate of inflation. … [Read more...]